Form 4 for NEPH NEPHROS INC
Accepted 2022-02-18 00:00:00 ET · period of report 2022-02-16 · accession 0001437749-22-003841 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-18 | 2022-02-16 | NEPH | Lobo Wesley S. | CMO | F - Tax | $4.80 | -6,389 | 35.2K | -15% | -$30.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-16 | F | D | 6,389 | $4.80 | 35,168 | D | — | — | (F1) The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock grant by directing the Company to withhold shares otherwise issuable upon vesting of the previously reported grant. (F2) Includes 15,000 shares of restricted stock for which the risk of forfeiture will lapse as to 5,000 shares on each of 2/16/23, 2/16/24 and 2/16/25. |